Skip to main content
. 2017 Jul 8;14(3):2603–2610. doi: 10.3892/ol.2017.6546

Figure 1.

Figure 1.

On the basis of the microarray data retrieved from Oncomine, SPARCL1 is differentially expressed in almost all tumors and a marked downregulation of SPARCL1 is observed in the majority of tumors. SPARCL1, SPARC-like protein 1; CNS, central nervous system; *total number of analyses in total number of datasets.